Talis Biomedical Corporation Variable Lease, Cost
Talis Biomedical Corporation reported Variable Lease, Cost of $787.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2024-03-28
- Talis Biomedical Corporation variable lease, cost for the quarter ending 2022-12-31 was $319.00K, a 963.33% increase year-over-year.
- Talis Biomedical Corporation variable lease, cost for the quarter ending 2022-09-30 was $321.00K, a 1046.43% increase year-over-year.
- Talis Biomedical Corporation variable lease, cost for the quarter ending 2022-06-30 was $160.00K, a 357.14% increase year-over-year.
- Talis Biomedical Corporation variable lease, cost for the quarter ending 2021-12-31 was $30.00K.
- Talis Biomedical Corporation variable lease, cost for fiscal 2023 was $787.00K, a 5.64% decline from fiscal 2022.
- Talis Biomedical Corporation variable lease, cost for fiscal 2022 was $834.00K, a 658.18% increase from fiscal 2021.
- Talis Biomedical Corporation variable lease, cost for fiscal 2021 was $110.00K, a 400.00% increase from fiscal 2020.
- Talis Biomedical Corporation variable lease, cost for fiscal 2020 was $22.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-12-31 | $787.00K 10-K · filed 2024-03-28 | |||
| 2022-12-31 | $319.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $640.00K derived: sum of 2 quarters · filed 2024-03-28 | $800.00K derived: sum of 3 quarters · filed 2024-03-28 | $834.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $321.00K 10-Q · filed 2022-11-03 | $481.00K derived: sum of 2 quarters · filed 2022-11-03 | $515.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $160.00K 10-Q · filed 2022-08-02 | $195.00K 10-Q · filed 2022-08-02 | ||
| 2021-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $58.00K derived: sum of 2 quarters · filed 2023-03-22 | $93.00K derived: sum of 3 quarters · filed 2023-03-22 | $110.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $28.00K 10-Q · filed 2022-11-03 | $63.00K derived: sum of 2 quarters · filed 2022-11-03 | $80.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $35.00K 10-Q · filed 2022-08-02 | $52.00K 10-Q · filed 2022-08-02 | ||
| 2020-12-31 | $22.00K 10-K · filed 2022-03-15 |